Effect on Gait Pattern During Robot Assisted Gait Training (RAGT) of End-effector Type in Burn Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorHangang Sacred Heart Hospital

About this trial

This study aimed to investigate gait pattern and muscles power improvement of patient with gait disturbance caused by burns after end-effector type robot (Morning Walk®)-assited gait training (RAGT). This study randomly assigned 36 patients to one of two group : 30 minutes of Morning Walk® training with 30 minutes conventional physiotherapy (RAGT group) or 60 minutes of conventional physiotherapy (CON group). Five training sessions per week were given for 8 weeks. The primary outcomes were gait performance and muscles powers, which were assessed by the functional ambulation category (FAC) and the manual muscles test (MMT), respectively. The secondary outcomes included 6-minute walking test (6MWT), gait kinematic and spatiotemporal gait parameters. The results of this study is anticipated that the patients with gait disturbance receiving the RAGT might improve greater in gait performance and normal gait patterns that those trained with conventional physiotherapy.

Eligibility criteria

Qualifiers

Patients who underwent split thickness skin graft (STSG) at Hangang Sacred Heart Hospital

with full or virtually full thickness involvement ( >50% of the body surface area of the lower extremity)

aged >18 years

with ≤ 1 functional ambulation category (FAC) score of ≤3 were included in this study.

Disqualifiers

who had fourth-degree burns (involving muscles, tendons, and bone injuries)

severe communication disorders due to intellectual impairment and psychologic problems

body weight > 135kg or height >195cm

physical status that could limit physical therapy (severe deformity or contracture of limbs, open wounds, or pressure ulcers, severe osteoporosis).

Trial design

Treatments tested in this trial

  • robot assisted gait training
  • conventional gait training

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators